PhaseWell Research Acquires Bio Behavioral Health
January 21, 2026
PhaseWell Research, a national clinical research site company, announced that Bio Behavioral Health has joined its network to expand access to neuropsychiatric and CNS clinical trials. The deal strengthens PhaseWell's community-based research capabilities and broadens patient access to complex clinical studies across its growing national footprint.
- Buyers
- PhaseWell Research
- Targets
- Bio Behavioral Health
- Platforms
- PhaseWell Research
- Industry
- Healthcare Services
- Location
- New Jersey, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
PhaseWell Research Acquires Chase Medical Research
March 19, 2026
Healthcare Services
PhaseWell Research, a multisite clinical research company headquartered in Nashville, Tennessee, announced it has acquired Chase Medical Research, a Connecticut-based clinical research site with locations in Waterbury and Hamden. The acquisition strengthens PhaseWell’s presence in the Northeast and expands its ability to support cardiometabolic and central nervous system clinical research in community-based settings.
-
Headlands Research Acquires Pharmasite Research
February 29, 2024
Healthcare Services
Headlands Research, a multinational network of clinical trial sites, has acquired Pharmasite Research, a Maryland-based clinical trial site focused on mental illness and central nervous system (CNS) disorders. The deal expands Headlands' therapeutic capabilities in mental health and extends its site network's reach in the Mid-Atlantic, bringing the network to 18 sites across the United States and Canada.
-
Summit BHC Acquires Seven Psychiatric Hospitals from Strategic Behavioral Health
January 6, 2022
Healthcare Services
Summit BHC, a national provider of behavioral health and addiction treatment services, has acquired seven inpatient psychiatric hospitals (613 beds total) from Strategic Behavioral Health. The deal expands Summit's footprint into New Mexico, North Carolina, and Wisconsin and increases its presence in Iowa, Tennessee, and Texas; terms were not disclosed.
-
Behavioral Health Group Acquires Center for Behavioral Health
January 13, 2022
Healthcare Services
Behavioral Health Group (BHG), a Vistria-backed national operator of outpatient opioid treatment centers, has acquired Center for Behavioral Health (CBH), a provider with 20 outpatient treatment centers across eight states. The acquisition expands BHG’s geographic footprint (adding presence in five new states) and increases its scale to roughly 116 treatment facilities and two labs nationwide.
-
Discovery Behavioral Health Acquires Anew Era TMS & Psychiatry
July 18, 2022
Healthcare Services
Discovery Behavioral Health acquired Anew Era TMS & Psychiatry, adding 12 outpatient TMS and psychiatry centers (six in California and six in Texas) to its network. The deal expands Discovery's outpatient psychiatry and neuromodulation capabilities as part of its Discovery MD professional psychiatric services division.
-
CVS Health Leads $25M Growth Round in Array Behavioral Care
June 1, 2023
Healthcare Services
Array Behavioral Care closed a $25 million equity financing round led by CVS Health, with participation from existing investors including Wells Fargo Strategic Capital, Health Velocity Capital, Harbour Point Capital, HLM Venture Partners, OCA Ventures, and OSF HealthCare. The capital will be used to scale Array’s virtual psychiatry and therapy services, enhance technology and operations, and expand access through deeper collaboration with CVS Health.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.